BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Salillas S, Alías M, Michel V, Mahía A, Lucía A, Rodrigues L, Bueno J, Galano-frutos JJ, De Reuse H, Velázquez-campoy A, Carrodeguas JA, Sostres C, Castillo J, Aínsa JA, Díaz-de-villegas MD, Lanas Á, Touati E, Sancho J. Design, Synthesis, and Efficacy Testing of Nitroethylene- and 7-Nitrobenzoxadiazol-Based Flavodoxin Inhibitors against Helicobacter pylori Drug-Resistant Clinical Strains and in Helicobacter pylori -Infected Mice. J Med Chem 2019;62:6102-15. [DOI: 10.1021/acs.jmedchem.9b00355] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Čėnas N, Nemeikaitė-Čėnienė A, Kosychova L. Single- and Two-Electron Reduction of Nitroaromatic Compounds by Flavoenzymes: Mechanisms and Implications for Cytotoxicity. Int J Mol Sci 2021;22:8534. [PMID: 34445240 DOI: 10.3390/ijms22168534] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Henriques PC, Costa LM, Seabra CL, Antunes B, Silva-Carvalho R, Junqueira-Neto S, Maia AF, Oliveira P, Magalhães A, Reis CA, Gartner F, Touati E, Gomes J, Costa P, Martins MCL, Gonçalves IC. Orally administrated chitosan microspheres bind Helicobacter pylori and decrease gastric infection in mice. Acta Biomater 2020;114:206-20. [PMID: 32622054 DOI: 10.1016/j.actbio.2020.06.035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
3 Ghobadi E, Ghanbarimasir Z, Emami S. A review on the structures and biological activities of anti-Helicobacter pylori agents. Eur J Med Chem 2021;223:113669. [PMID: 34218084 DOI: 10.1016/j.ejmech.2021.113669] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Hu Y, Zhu Y, Lu NH. Recent progress in Helicobacter pylori treatment. Chin Med J (Engl). 2020;133:335-343. [PMID: 31929363 DOI: 10.1097/cm9.0000000000000618] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
5 González A, Casado J, Gündüz MG, Santos B, Velázquez-campoy A, Sarasa-buisan C, Fillat MF, Montes M, Piazuelo E, Lanas Á. 1,4-Dihydropyridine as a Promising Scaffold for Novel Antimicrobials Against Helicobacter pylori. Front Microbiol 2022;13:874709. [DOI: 10.3389/fmicb.2022.874709] [Reference Citation Analysis]
6 Salillas S, Galano-Frutos JJ, Mahía A, Maity R, Conde-Giménez M, Anoz-Carbonell E, Berlamont H, Velazquez-Campoy A, Touati E, Mamat U, Schaible UE, Gálvez JA, Díaz-de-Villegas MD, Haesebrouck F, Aínsa JA, Sancho J. Selective Targeting of Human and Animal Pathogens of the Helicobacter Genus by Flavodoxin Inhibitors: Efficacy, Synergy, Resistance and Mechanistic Studies. Int J Mol Sci 2021;22:10137. [PMID: 34576300 DOI: 10.3390/ijms221810137] [Reference Citation Analysis]
7 González A, Casado J, Chueca E, Salillas S, Velázquez-Campoy A, Espinosa Angarica V, Bénejat L, Guignard J, Giese A, Sancho J, Lehours P, Lanas Á. Repurposing Dihydropyridines for Treatment of Helicobacter pylori Infection. Pharmaceutics 2019;11:E681. [PMID: 31847484 DOI: 10.3390/pharmaceutics11120681] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
8 Salillas S, Sancho J. Flavodoxins as Novel Therapeutic Targets against Helicobacter pylori and Other Gastric Pathogens. Int J Mol Sci 2020;21:E1881. [PMID: 32164177 DOI: 10.3390/ijms21051881] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Wang B, Zhang J, Chen S, Bie M. Helicobacter pylori and gastrointestinal and neurological diseases: Study protocol of an umbrella review of systematic reviews and meta-analyses. Medicine (Baltimore) 2019;98:e18460. [PMID: 31876728 DOI: 10.1097/MD.0000000000018460] [Reference Citation Analysis]
10 Boyanova L, Hadzhiyski P, Kandilarov N, Markovska R, Mitov I. Multidrug resistance in Helicobacter pylori: current state and future directions. Expert Rev Clin Pharmacol. 2019;12:909-915. [PMID: 31424296 DOI: 10.1080/17512433.2019.1654858] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
11 Xu M, Zhou J, Heng D, Su X, Onakpa MM, Bai Y, Duan JA, Che CT, Bi H, Zhao M. Quinone Derivatives as Promising Anti-Helicobacter pylori Agents from Aerial Parts of Mitracarpus hirtus. J Nat Prod 2022. [PMID: 35412828 DOI: 10.1021/acs.jnatprod.1c01163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Mancini RS, Barden CJ, Weaver DF, Reed MA. Furazans in Medicinal Chemistry. J Med Chem 2021;64:1786-815. [PMID: 33569941 DOI: 10.1021/acs.jmedchem.0c01901] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Xu M, Zhou J, Zeng L, Xu J, Onakpa MM, Duan J, Che C, Bi H, Zhao M. Pimarane-derived diterpenoids with anti- Helicobacter pylori activity from the tuber of Icacina trichantha. Org Chem Front 2021;8:3014-22. [DOI: 10.1039/d1qo00374g] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]